Patents by Inventor Craig Laferriere

Craig Laferriere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080081050
    Abstract: The present invention relates to a combination of 2 or more S pneumoniae proteins, their manufacture and use in medicine as a vaccine. Such combinations are particularly useful for the protection of infants and elderly against streptococcal infection.
    Type: Application
    Filed: May 7, 2007
    Publication date: April 3, 2008
    Inventors: Philippe Hermand, Craig Laferriere, Yves Lobet, Jan Poolman
  • Publication number: 20060093626
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular the present invention relates to specific advantageous pneumococcal polysaccharide conjugates adjuvanted with 3D-MPL and substantially devoid of aluminium-based adjuvant.
    Type: Application
    Filed: September 30, 2005
    Publication date: May 4, 2006
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Publication number: 20060051361
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen from Streptococcus pneumoniae selected from the group consisting of PhtA, PhtD, PhtB, PhtE, SpsA, LytB, LytC, LytA, Sp125, Sp101, Sp128, Sp130 and Sp133, and optionally a Th1-inducing adjuvant.
    Type: Application
    Filed: September 12, 2001
    Publication date: March 9, 2006
    Inventors: Craig Laferriere, Jan Poolman
  • Publication number: 20060002961
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form Streptococcus pneumoniae, and optionally a Th1-inducing adjuvant.
    Type: Application
    Filed: August 31, 2005
    Publication date: January 5, 2006
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Publication number: 20050214329
    Abstract: The present invention provides an optimal formulation of multiple serotype Streptococcus pneumoniae conjugate vaccines.
    Type: Application
    Filed: December 18, 2002
    Publication date: September 29, 2005
    Inventors: Craig Laferriere, Jan Poolman
  • Publication number: 20050031646
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H influenzae.
    Type: Application
    Filed: August 27, 2004
    Publication date: February 10, 2005
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Patent number: 5192661
    Abstract: A compound X-Y wherein X comprises sialic acid, a sialic acid derivative or and oligosaccharide terminating in a sialic acid or sialic acid derivative if multibranched at the end of at least the largest branch, and, Y represents coupling means which allows an antibody to be raised to X when the compound is coupled to a carrier through the coupling nears Y and the coupled compound used to raise said antibody. These compounds show utility in that they, and antibodies raised against these, can be used in detecting and diagnosing cancers.
    Type: Grant
    Filed: May 31, 1991
    Date of Patent: March 9, 1993
    Assignee: University of Ottawa
    Inventors: Rene Roy, Craig A. Laferriere
  • Patent number: 5034516
    Abstract: A compound X-Y wherein X comprises sialic acid, a sialic acid derivative or an oligosaccharide terminating in a sialic acid or sialic acid derivative if multibranched at the end of at least the largest branch, and, Y represents coupling means which allows an antibody to be raised to X when the compound is coupled to a carrier through the coupling means Y and the coupled compound used to raise said antibody. These compounds show utility in that they, and antibodies raised against these, can be used in detecting and diagnosing cancers.
    Type: Grant
    Filed: August 4, 1987
    Date of Patent: July 23, 1991
    Assignee: University of Ottawa
    Inventors: Rene Roy, Craig A. Laferriere